Loading clinical trials...
Loading clinical trials...
This observational study aims to recruit pregnant women between 18 to 24 weeks of gestation to investigate the relationship between amniotic membrane thickness and fetal chromosomal abnormalities. The...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tianjin Central Hospital of Gynecology Obstetrics
NCT00227253 · Chromosome Aberrations, Growth Hormone Deficiency, and more
NCT00341900 · Frequency of Chromosome Aberrations
NCT00471731 · Turner Syndrome, Ovarian Failure, Premature, and more
Tianjin Central Hospital of Obstetrics and Gynecology
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions